KLF14 and Hepatic fibrosis: Considering KLF14 overexpression inhibited liver fibrosis in vitro and in vivo, and KLF14 expression was robustly reactivated upon EPZ‐6438 in vitro treatment, we aimed to investigate whether in vivo administration of EPZ‐6438 affected the progression of liver fibrosis.